Nevada
|
0-30379
|
88-0425691
|
||
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
||
of
Incorporation)
|
Identification
Number)
|
|||
3661
Horseblock Road
|
||||
Medford,
NY 11763
|
||||
(Address
of principal executive offices)
|
||||
631-924-1135
|
||||
(Registrant’s
Telephone Number)
|
(a)
|
On
August 14, 2006 the Registrant issued the press release titled
“Chembio
Reports Second Quarter and First Half 2006 Financial
Results”
|
(b)
|
On
August 15, 2006 the Registrant issued the press release titled
“Chembio to
Feature New Procedure for Rapid HIV Test at International Aids
Conference”
|
99.1
|
Press
Release titled “Chembio Reports Second Quarter and
First Half 2006 Financial Results” issued August 14,
2006.
|
99.2
|
Press
Release titled “Chembio to Feature New Procedure for
Rapid HIV Test at International Aids Conference” issued August 15,
2006.
|
·
|
Received
an approval letter from the FDA for its SURE CHECK(R) HIV 1/2
and HIV 1/2
STAT-PAK(TM) rapid test Pre-Market Applications (PMAs). Chembio
is in
discussions with potential partners for the marketing of these
FDA
approved products in the U.S. We have also submitted Clinical
Laboratory
Improvement Act (“CLIA”) waiver applications for these
products.
|
·
|
Introduced
initial prototypes of a new patent pending rapid test technology,
Dual
Path Platform (DPP(TM)), that offers significant advantages
over
conventional single path lateral flow technology. Chembio intends
to
develop new tests using the DPP as well as license it to other
companies
for use in their tests. Chembio has completed initial internal
studies on
an HIV test using the DPP and oral fluid
samples.
|
·
|
Shipped
our first orders to Nigeria based upon the Nigerian Ministry
of Health
designating Chembio’s HIV 1/2 STAT-PAK(TM) as a screening test in four out
of the eight testing protocols that comprise Nigeria's Interim
National
Testing Algorithm.
|
Chembio
Diagnostics, Inc.
|
|||||||||||||
Summary
of Results of Operations
|
|||||||||||||
Second
Quarter 2006
|
Second
Quarter 2005
|
First
Six months of 2006
|
First
Six months of 2005
|
||||||||||
Total
Revenues
|
$
|
1,637,236
|
$
|
905,689
|
$
|
2,874,903
|
$
|
1,637,574
|
|||||
Gross
Profit
|
564,434
|
269,309
|
999,973
|
536,644
|
|||||||||
Operating
Loss
|
(1,120,352
|
)
|
(886,908
|
)
|
(2,375,266
|
)
|
(1,510,383
|
)
|
|||||
Net
Loss
|
(1,127,375
|
)
|
(875,142
|
)
|
(2,391,090
|
)
|
(1,495,127
|
)
|
|||||
Preferred
Dividends
|
207,937
|
212,061
|
420,860
|
394,239
|
|||||||||
Accreted
Beneficial Conversion to preferred stock
|
-
|
-
|
463,434
|
2,698,701
|
|||||||||
Net
Loss Attributable to Common Stockholders
|
(1,335,312
|
)
|
(1,087,203
|
)
|
(3,275,384
|
)
|
(4,588,067
|
)
|
|||||
Loss
per share
|
$
|
(0.13
|
)
|
$
|
(0.15
|
)
|
$
|
(0.34
|
)
|
$
|
(0.64
|
)
|